Diabetes Stem Cell Therapy Global Market Report 2025
상품코드:1889359
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
당뇨병 줄기세포 치료 시장의 규모는 최근 급속도로 확대되고 있습니다. 2024년 26억 8,000만 달러에서 2025년에는 30억 1,000만 달러에 달하고, CAGR 12.3%로 성장할 것으로 예상되고 있습니다. 지난 수년간의 성장은 당뇨병의 유병률 증가, 의료 지출 확대, 재생의료에 대한 인지도 향상, 줄기세포 연구에 대한 정부 지원 강화, 임상시험 인프라 정비가 진행된 것 등이 요인으로 추측됩니다.
당뇨병 줄기세포 치료 시장의 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 47억 4,000만 달러에 이르고 CAGR은 12.0%를 나타낼 전망입니다. 예측기간의 성장은 맞춤형 의료에 대한 수요 증가, 줄기세포 치료 클리닉 수 증가, 생명공학 분야에 대한 투자 확대, 유리한 환급 정책 증가, 첨단 치료 솔루션의 보급 확대에 의해 견인될 전망입니다. 예측기간의 주요 동향으로는 줄기세포공학의 기술적 진보, 세포 전달 시스템의 혁신, 재생 의료 프로토콜의 발전, 치료 설계에 있어서의 인공지능의 통합, 바이오 테크놀로지 기업과 연구 기관과의 제휴 등을 들 수 있습니다.
향후 수년간, 신규 치료에 대한 수요 증가가 당뇨병 줄기세포 치료 시장의 성장을 견인할 것으로 예측됩니다. 새로운 치료법은 기존의 질병 관리에서 사용할 수 없었던 새로운 메커니즘, 표적 또는 접근법을 사용하는 치료법을 의미합니다. 복잡한 만성 질환의 유병률이 증가하고 있는 것 외에도, 종래의 치료법은 효과적 또는 장기적 해결책을 제공하지 못하는 경우가 많기 때문에 새로운 치료법에 대한 수요는 증가하고 있습니다. 당뇨병 줄기세포 치료는 췌장 기능을 회복시키고, 인슐린 의존도를 감소시키며, 당뇨병의 장기적인 치료법을 제공할 잠재력을 갖춘 재생 의료 솔루션을 제공함으로써 이러한 요구를 충족시킵니다. 예를 들어, 2025년 1월에 국립생물공학정보센터(NCBI)가 보고한 바에 의하면, 신규 승인된 의약품은 1,035품목이었으며, 그 중 337품목이 신규 치료제(신약)로, 81품목이 혁신 요법(신규 치료법)에 해당하고, 신규 승인 전체의 24%를 차지하였습니다. 따라서, 신규 치료법에 대한 수요 증가가 당뇨병 줄기세포 치료 시장을 견인하고 있습니다.
당뇨병 줄기세포 치료 시장의 기업은 생명공학, 줄기세포 연구, 재생의료 진보에 주력하고 1형 당뇨병 환자의 인슐린 생산 능력을 회복시키고 혈당 조절을 개선하는 세포요법을 제공하기 위해 노력하고 있습니다. 이러한 접근법은 살아있는 세포, 조직, 분자 기술을 사용하여 손상된 장기와 세포를 복구, 대체, 재생하여 만성 질환에 대한 고급 치료 옵션을 제공합니다. 2023년 6월 미국 바이오테크놀러지 기업 셀트랜스사는 심한 저혈당을 반복적으로 경험하는 성인 1형 당뇨병 환자를 대상으로 사망 기증자 췌장세포에서 제조된 세계 최초의 동종 췌도 세포요법 '란티드라'에 대해 FDA의 승인을 받았습니다. 이식된 췌도 베타 세포는 간문맥으로의 단일 주입에 의해 투여되어 인슐린을 분비합니다. 이를 통해 일부 환자는 1년 이상 최대 5년 동안 인슐린에 대해 독립적인 상태를 유지할 수 있어 질병 관리, 혈당 조절, 삶의 질이 크게 향상됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 당뇨병 줄기세포 치료 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 당뇨병 줄기세포 치료 시장 : 성장률 분석
세계의 당뇨병 줄기세포 치료 시장 실적 : 규모와 성장(2019-2024년)
세계의 당뇨병 줄기세포 치료 시장 예측 : 규모와 성장(2024-2029년, 2034F)
세계의 당뇨병 줄기세포 치료 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 당뇨병 줄기세포 치료 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
전임상
1상 및 2상
세계의 당뇨병 줄기세포 치료 시장 치료법 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
자가 줄기 세포 치료
동종 줄기세포 치료
유도 만능 줄기세포(iPS세포) 요법
중간엽 줄기세포(MSC) 요법
조혈 줄기세포 치료
세계의 당뇨병 줄기세포 치료 시장 : 전달방법별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
정맥내 주사
근육내 주사
췌장내 주사
국소 조직 투여
세계의 당뇨병 줄기세포 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
1형 당뇨병 치료
2형 당뇨병 관리
당뇨병 합병증 치료
췌도 세포 이식
세계의 당뇨병 줄기세포 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
병원
연구기관
당뇨병 클리닉
제약기업
세계의 당뇨병 줄기세포 치료 시장 세분화 : 전임상, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
배아 줄기세포 치료
인공 만능 줄기세포 요법
중간엽 줄기세포 요법
조혈 줄기세포 치료
세계의 당뇨병 줄기세포 치료 시장 세분화 : 1상 및 2상, 유형별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
자가 줄기세포 치료
동종 줄기세포 치료
췌도 세포 요법
캡슐화 세포 요법
β 세포 치환 요법
면역조절요법
유전자 변형 줄기세포 요법
복합 줄기세포 요법
제7장 지역별 및 국가별 분석
세계의 당뇨병 줄기세포 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
세계의 당뇨병 줄기세포 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029F, 2034F)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
당뇨병 줄기세포 치료 시장 : 경쟁 구도
당뇨병 줄기세포 치료 시장 : 기업 프로파일
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Gilead Sciences Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Mesoblast Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Evotec SE : 개요, 제품 및 서비스, 전략 및 재무 분석
Swiss Medica Stem Cells SA : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Aspect Biosystems Ltd.
Celltex Therapeutics Corporation
Adocia SA
Seraxis Inc.
BrainStorm Cell Therapeutics Inc.
Sernova Corporation
Betalin Therapeutics Ltd.
NextCell Pharma AB
PharmaCyte Biotech Inc.
Global Institute for Stem Cell Therapy and Research
Throne Biotechnologies Inc.
Orgenesis Inc.
Holostem Terapie Avanzate Srl
Anterogen Co. Ltd.
Juventa Regenerative Medicine Inc.
제32장 세계 시장의 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
당뇨병 줄기세포 치료 시장(2029년) : 새로운 기회를 제공하는 국가
당뇨병 줄기세포 치료 시장(2029년) : 새로운 기회를 제공하는 부문
당뇨병 줄기세포 치료 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
CSM
영문 목차
영문목차
Diabetes stem cell therapy refers to a medical approach that uses stem cells to treat or manage diabetes by regenerating, replacing, or repairing damaged pancreatic cells, particularly insulin-producing beta cells. It is widely used in clinical research and regenerative medicine to improve blood glucose control, reduce diabetes-related complications, and support potential long-term disease management.
The primary types of therapies in the diabetes stem cell therapy market include preclinical and clinical phase 1 and 2 therapies. Preclinical therapies refer to treatments in the experimental stage, typically tested in laboratory and animal models to assess safety, efficacy, and potential therapeutic benefits before progressing to human clinical trials. These therapies include autologous, allogeneic, induced pluripotent, mesenchymal, and hematopoietic stem cell treatments, delivered through methods such as intravenous injection, intramuscular injection, intra-pancreatic injection, and local tissue delivery. They are applied in areas such as type 1 diabetes treatment, type 2 diabetes management, diabetic complication treatment, and islet cell transplantation, and are primarily utilized by hospitals, research institutes, diabetes clinics, and pharmaceutical companies.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The diabetes stem cell therapy market research report is one of a series of new reports from The Business Research Company that provides diabetes stem cell therapy market statistics, including the diabetes stem cell therapy industry global market size, regional shares, competitors with the diabetes stem cell therapy market share, detailed diabetes stem cell therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the diabetes stem cell therapy industry. This diabetes stem cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The diabetes stem cell therapy market size has grown rapidly in recent years. It will grow from $2.68 billion in 2024 to $3.01 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be linked to the growing prevalence of diabetes, rising healthcare expenditure, increasing awareness about regenerative therapies, growing government support for stem cell research, and increasing availability of clinical trial infrastructure.
The diabetes stem cell therapy market size is expected to see rapid growth in the next few years. It will grow to $4.74 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The growth in the forecast period can be driven by increasing demand for personalized medicine, a rising number of stem cell therapy clinics, growing investment in biotechnology, increasing favorable reimbursement policies, and growing adoption of advanced therapeutic solutions. Major trends in the forecast period include technological advancements in stem cell engineering, innovations in cell delivery systems, developments in regenerative medicine protocols, integration of artificial intelligence in therapy design, and collaborations between biotech companies and research institutes.
The growing need for novel treatments is expected to drive the growth of the diabetes stem cell therapy market in the coming years. Novel treatments are therapies that use new mechanisms, targets, or approaches not previously available for disease management. This demand is rising due to the increasing prevalence of complex and chronic diseases, as conventional therapies often fail to provide effective or long-term solutions. Diabetes stem cell therapy addresses this need by offering regenerative solutions that can restore pancreatic function, reduce insulin dependence, and potentially provide a long-term cure for diabetes. For instance, in January 2025, the National Center for Biotechnology Information (NCBI) reported that 1,035 new drugs were approved, of which 337 were novel drugs, including 81 first-in-class therapies, accounting for 24% of all novel approvals. Consequently, the growing need for novel treatments is fueling the diabetes stem cell therapy market.
Companies in the diabetes stem cell therapy market are focusing on advances in biotechnology, stem cell research, and regenerative medicine to provide cellular therapies that restore insulin production and improve glycemic control in patients with type 1 diabetes. These approaches involve the use of living cells, tissues, and molecular techniques to repair, replace, or regenerate damaged organs or cells, offering advanced treatment options for chronic diseases. In June 2023, CellTrans Inc., a US-based biotechnology firm, received FDA approval for Lantidra, the first allogeneic pancreatic islet cellular therapy made from deceased donor pancreatic cells for adults with type 1 diabetes experiencing recurrent severe hypoglycemia. Administered via a single infusion into the hepatic portal vein, the transplanted islet beta cells secrete insulin, allowing some patients to achieve insulin independence for one year or more, with cases extending up to five years, significantly improving disease management, glycemic control, and quality of life.
In June 2023, Eli Lilly and Company, a US-based pharmaceutical firm, acquired Sigilon Therapeutics Inc. for $309.6 million. Through this acquisition, Eli Lilly aims to strengthen its capabilities in encapsulated cell-therapy solutions for type 1 diabetes by integrating Sigilon's shielded-cell technology into its portfolio. Sigilon Therapeutics Inc. is a US-based biopharmaceutical company developing stem cell-based therapies for type 1 diabetes.
Major companies operating in the diabetes stem cell therapy market are Bristol-Myers Squibb Company, Gilead Sciences Inc., Mesoblast Limited, Evotec SE, Swiss Medica Stem Cells SA, Aspect Biosystems Ltd., Celltex Therapeutics Corporation, Adocia SA, Seraxis Inc., BrainStorm Cell Therapeutics Inc., Sernova Corporation, Betalin Therapeutics Ltd., NextCell Pharma AB, PharmaCyte Biotech Inc., Global Institute for Stem Cell Therapy and Research, Throne Biotechnologies Inc., Orgenesis Inc., Holostem Terapie Avanzate S.r.l., Anterogen Co. Ltd., Juventa Regenerative Medicine Inc.
North America was the largest region in the diabetes stem cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diabetes stem cell therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the diabetes stem cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The diabetes stem cell therapy market consists of revenues earned by entities by providing services such as stem cell transplantation services, quality control testing, logistics and cryopreservation services, and patient monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diabetes stem cell therapy market also includes sales of bioreactors, syringes, cell therapy kits, diagnostic kits, and laboratory consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diabetes Stem Cell Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on diabetes stem cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for diabetes stem cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes stem cell therapy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Preclinical; Clinical Phase 1,2
3. Diabetes Stem Cell Therapy Market Trends And Strategies
4. Diabetes Stem Cell Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Diabetes Stem Cell Therapy Growth Analysis And Strategic Analysis Framework
5.1. Global Diabetes Stem Cell Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Diabetes Stem Cell Therapy Market Growth Rate Analysis
5.4. Global Diabetes Stem Cell Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Diabetes Stem Cell Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Diabetes Stem Cell Therapy Total Addressable Market (TAM)
6. Diabetes Stem Cell Therapy Market Segmentation
6.1. Global Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Preclinical
Clinical Phase 1,2
6.2. Global Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous Stem Cell Therapy
Allogeneic Stem Cell Therapy
Induced Pluripotent Stem Cell (iPSC) Therapy
Mesenchymal Stem Cell (MSC) Therapy
Hematopoietic Stem Cell Therapy
6.3. Global Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Injection
Intramuscular Injection
Intra-Pancreatic Injection
Local Tissue Delivery
6.4. Global Diabetes Stem Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type 1 Diabetes Treatment
Type 2 Diabetes Management
Diabetic Complications Treatment
Islet Cell Transplantation
6.5. Global Diabetes Stem Cell Therapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Diabetes Clinics
Pharmaceutical Companies
6.6. Global Diabetes Stem Cell Therapy Market, Sub-Segmentation Of Preclinical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Embryonic Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
Mesenchymal Stem Cell Therapy
Hematopoietic Stem Cell Therapy
6.7. Global Diabetes Stem Cell Therapy Market, Sub-Segmentation Of Clinical Phase 1 And 2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous Stem Cell Therapy
Allogeneic Stem Cell Therapy
Pancreatic Islet Cell Therapy
Encapsulated Cell Therapy
Beta Cell Replacement Therapy
Immune Modulation Therapy
Gene-Modified Stem Cell Therapy
Combination Stem Cell Therapy
7. Diabetes Stem Cell Therapy Market Regional And Country Analysis
7.1. Global Diabetes Stem Cell Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Diabetes Stem Cell Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Diabetes Stem Cell Therapy Market
9.1. China Diabetes Stem Cell Therapy Market Overview
9.2. China Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Diabetes Stem Cell Therapy Market
10.1. India Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Diabetes Stem Cell Therapy Market
11.1. Japan Diabetes Stem Cell Therapy Market Overview
11.2. Japan Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Diabetes Stem Cell Therapy Market
12.1. Australia Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Diabetes Stem Cell Therapy Market
13.1. Indonesia Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Diabetes Stem Cell Therapy Market
14.1. South Korea Diabetes Stem Cell Therapy Market Overview
14.2. South Korea Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Diabetes Stem Cell Therapy Market
15.1. Western Europe Diabetes Stem Cell Therapy Market Overview
15.2. Western Europe Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Diabetes Stem Cell Therapy Market
16.1. UK Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Diabetes Stem Cell Therapy Market
17.1. Germany Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Diabetes Stem Cell Therapy Market
18.1. France Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Diabetes Stem Cell Therapy Market
19.1. Italy Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Diabetes Stem Cell Therapy Market
20.1. Spain Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Diabetes Stem Cell Therapy Market
21.1. Eastern Europe Diabetes Stem Cell Therapy Market Overview
21.2. Eastern Europe Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Diabetes Stem Cell Therapy Market
22.1. Russia Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Diabetes Stem Cell Therapy Market
23.1. North America Diabetes Stem Cell Therapy Market Overview
23.2. North America Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Diabetes Stem Cell Therapy Market
24.1. USA Diabetes Stem Cell Therapy Market Overview
24.2. USA Diabetes Stem Cell Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Diabetes Stem Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Diabetes Stem Cell Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
